Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a ...

Drugs used to treat diabetes and obesity, or GLP-1 (Glucagon-like peptide-1), will be a significant growth driver for ...

Her suggestions included adding dupilumab and other biologics to the list of subsidised drugs and for moderate to severe ...

Medicare drug price negotiation could have significant impacts on investment in post-approval studies for cancer treatment ...

A coalition of pharmaceutical companies and conservation groups launched the Sustainability Scorecard for Endotoxin Testing ...

Egypt was added to the list of malaria-free places in 2024, but climate change, conflict and other threats could increase cases especially in Africa.

The prevalence of eczema in Singapore has been largely stable in the past decade, affecting about one in five children and ...

Breakthroughs in synthetic biology could create mirror versions of natural molecules, with devastating consequences for life ...

For instance, researchers sometimes use biobanks — collections of medical and biological ... Myfembree in 2022. The drugs ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

We recently published a list of Jim Cramer’s Latest Calls: Top 10 Stocks. In this article, we are going to take a look at ...

OneSource has clients in America, Europe, the Middle East, Africa, and India, all looking at GLP-1 opportunities. The market ...